GL1X · GenesisL1 explorer

UniProt P21580

Tumor necrosis factor alpha-induced protein 3 (P21580)

Tumor necrosis factor alpha-induced protein 3 (UniProt P21580), EC 3.4.19.12, 6.3.2.-: 33 experimental structures and 1 predicted model on GenesisL1, 1 ligand bound, 25 pockets. Binding sites, druggability and experiment against…

UniProt
P21580
Protein
Tumor necrosis factor alpha-induced protein 3
EC
3.4.19.12, 6.3.2.-
Experimental structures
33
Predicted models
1
Ligands
1
Pockets
25 · 2 records with a druggable one

Structures

34 records of P21580 in the MolNFT archive: 33 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
2EQESolution structure of the fourth A20-type zinc finger domain from human tumor necrosis factor…solution nmrA——
2EQESolution structure of the fourth A20-type zinc finger domain from human tumor necrosis factor…solution nmrA——
2EQFSolution structure of the 7th A20-type zinc finger domain from human tumor necrosis factor…solution nmrA——
2EQFSolution structure of the 7TH A20-type zinc finger domain from human tumor necrosis factor…solution nmrA——
2EQGSolution structure of the first A20-type zinc finger domain from human tumor necrosis factor…solution nmrA——
2EQGSolution structure of the first A20-type zinc finger domain from human tumor necrosis factor…solution nmrA——
2VFJStructure of the A20 Ovarian Tumour (OTU) domainx-ray diffractionA, B, C, D——
2VFJStructure of the A20 ovarian tumour (otu) domainx-ray diffractionA, B, C, D——
3DKBCrystal Structure of A20, 2.5 angstromx-ray diffractionA, B, C, D, E, F——
3DKBCrystal structure of A20, 2.5 ångströmx-ray diffractionA, B, C, D, E, F——
3OJ3Crystal structure of the A20 ZnF4 and ubiquitin complexx-ray diffractionI, J, K, L, M, N, O, P——
3OJ3Crystal structure of the A20 ZNF4 and ubiquitin complexx-ray diffractionI, J, K, L, M, N, O, P——
3OJ4Crystal structure of the A20 ZnF4, ubiquitin and UbcH5A complexx-ray diffractionC, F——
3OJ4Crystal structure of the A20 ZNF4, ubiquitin and UBCH5A complexx-ray diffractionC, F——
3VUWCrystal structure of A20 ZF7 in complex with linear ubiquitin, form Ix-ray diffractionE, F, G——
3VUWCrystal structure of A20 ZF7 in complex with linear ubiquitin, form Ix-ray diffractionE, F, G——
3VUXCrystal structure of A20 ZF7 in complex with linear ubiquitin, form IIx-ray diffractionE, F, G——
3VUXCrystal structure of A20 ZF7 in complex with linear ubiquitin, form IIx-ray diffractionE, F, G——
3VUYCrystal structure of A20 ZF7 in complex with linear tetraubiquitinx-ray diffractionD, F, E——
3VUYCrystal structure of A20 ZF7 in complex with linear tetraubiquitinx-ray diffractionD, F, E——
3ZJDA20 OTU domain in reduced, active state at 1.87 A resolutionx-ray diffractionA, B——
3ZJDA20 otu domain in reduced, active state at 1.87 a resolutionx-ray diffractionA, B——
3ZJEA20 OTU domain in reversibly oxidised (SOH) statex-ray diffractionA, B——
3ZJEA20 otu domain in reversibly oxidised (soh) statex-ray diffractionA, B——
3ZJFA20 OTU domain with irreversibly oxidised Cys103 from 270 min H2O2 soak.x-ray diffractionA, B——
3ZJFA20 otu domain with irreversibly oxidised CYS103 from 270 min H2O2 soak.x-ray diffractionA, B——
3ZJGA20 OTU domain with irreversibly oxidised Cys103 from 60 min H2O2 soak.x-ray diffractionA, B——
3ZJGA20 otu domain with irreversibly oxidised CYS103 from 60 min H2O2 soak.x-ray diffractionA, B——
5LRXStructure of A20 OTU domain bound to ubiquitinx-ray diffractionA, C, E, F——
5LRXStructure of A20 otu domain bound to ubiquitinx-ray diffractionA, C, E, FAYE—
5V3BHuman A20 otu domain (wt) with acetamidylated C103x-ray diffractionA, B, C, D, E, F——
5V3PHuman A20 OTU domain (I325N) with acetamidylated C103x-ray diffractionA, B, C, D, E, F—20 (best 0.54)
5V3PHuman A20 otu domain (I325N) with acetamidylated C103x-ray diffractionA, B, C, D, E, F——
P21580AlphaFold monomer V2.0 prediction for tumor necrosis factor alpha- induced protein 3 (P21580)predictedA—5 (best 0.64)

Ligands

  • AYE · prop-2-en-1-amine · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.